Bluejay Diagnostics, Inc. Current Liabilities
Bluejay Diagnostics, Inc. (BJDX) had Current Liabilities of $2.12 million as of 2026-06-30, per its 10-Q filed 2026-08-12.
Financial Statements › Balance Sheet › Liabilities › Liabilities, Current
us-gaap:LiabilitiesCurrent · last filed 2026-08-12
- 2026-06-30: Liabilities, Current $2.12M.
- 2026-03-31: Liabilities, Current $1.41M.
- 2025-12-31: Liabilities, Current $1.12M.
- 2025-09-30: Liabilities, Current $1.15M.
| Period end | Liabilities, Current |
|---|---|
| 2026-06-30 | $2.12M 10-Q · filed 2026-08-12 |
| 2026-03-31 | $1.41M 10-Q · filed 2026-05-07 |
| 2025-12-31 | $1.12M 10-Q · filed 2026-08-12 |
| 2025-09-30 | $1.15M 10-Q · filed 2025-11-07 |
| 2025-06-30 | $1.04M 10-Q · filed 2025-08-07 |
| 2025-03-31 | $1.32M 10-Q · filed 2025-05-13 |
| 2024-12-31 | $810.37K 10-K · filed 2026-03-06 |
| 2024-09-30 | $1.05M 10-Q · filed 2024-11-07 |
| 2024-06-30 | $2.06M 10-Q · filed 2024-08-14 |
| 2024-03-31 | $1.53M 10-Q · filed 2024-05-15 |
| 2023-12-31 | $1.77M 10-K · filed 2025-03-31 |
| 2023-09-30 | $2.80M 10-Q · filed 2023-11-09 |
| 2023-06-30 | $1.83M 10-Q · filed 2023-08-14 |
| 2023-03-31 | $1.42M 10-Q · filed 2023-05-11 |
| 2022-12-31 | $1.64M 10-K · filed 2024-03-28 |
| 2022-09-30 | $1.52M 10-Q · filed 2022-11-09 |
| 2022-06-30 | $979.59K 10-Q · filed 2022-08-10 |
| 2022-03-31 | $1.31M 10-Q · filed 2022-05-09 |
| 2021-12-31 | $637.16K 10-K · filed 2023-03-20 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| OSR Health, Inc. (OSRH) | United States | $0.004B | -0.75 |
| Adagio Medical Holdings, Inc. (ADGM) | United States | $0.004B | |
| Autonomix Medical, Inc. (AMIX) | United States | $0.004B | |
| AETHLON MEDICAL INC (AEMD) | United States | $0.005B | |
| INTELLIGENT BIO SOLUTIONS INC. (INBS) | United States | $0.005B | |
| Beyond Air, Inc. (XAIR) | United States | $0.003B | -0.01 |
| Vivos Therapeutics, Inc. (VVOS) | United States | $0.003B | -0.26 |
| Sonoma Pharmaceuticals, Inc. (SNOA) | United States | $0.006B | -2.59 |
| NEXGEL, INC. (NXGL) | United States | $0.002B | |
| INVO Fertility, Inc. (IVF) | United States | $0.002B | -0.71 |